96 related articles for article (PubMed ID: 14655770)
1. Learning curve.
Weinberg JM
Cutis; 2003 Nov; 72(5):349. PubMed ID: 14655770
[No Abstract] [Full Text] [Related]
2. [Biological therapeutic agents and patient autonomy in dermatologic therapy. The Danish Society of Dermatology].
Bygum A; Jemec GB
Ugeskr Laeger; 2004 Mar; 166(12):1105. PubMed ID: 15067764
[No Abstract] [Full Text] [Related]
3. [Biological dermatologic agents. The Danish Society of Dermatology].
Iversen L; Kragballe K;
Ugeskr Laeger; 2007 Mar; 169(12):1100. PubMed ID: 17394811
[No Abstract] [Full Text] [Related]
4. Alefacept for psoriasis.
Heffernan MP; Leonardi CL
Semin Cutan Med Surg; 2010 Mar; 29(1):53-5. PubMed ID: 20430308
[No Abstract] [Full Text] [Related]
5. Treatment of palmoplantar psoriasis with intramuscular alefacept.
Myers W; Christiansen L; Gottlieb AB
J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 1):S127-9. PubMed ID: 16021161
[TBL] [Abstract][Full Text] [Related]
6. Alefacept treatment for chronic plaque psoriasis.
Dunn LK; Feldman SR
Skin Therapy Lett; 2010 Apr; 15(4):1-3. PubMed ID: 20361167
[TBL] [Abstract][Full Text] [Related]
7. Treating psoriasis patients with biologic agents.
Pariser DM
Manag Care; 2003 Dec; 12(12):50-7; discussion 57-9; quiz 60-2. PubMed ID: 14723104
[No Abstract] [Full Text] [Related]
8. Preface: real-world clinical experience with alefacept-the Amevive Wisdom Acquired from Real-World Evidence (AWARE) study.
Searles G; Bissonnette R; Landells I; Shear NH
J Cutan Med Surg; 2009 Dec; 13 Suppl 3():S107-12. PubMed ID: 20053322
[No Abstract] [Full Text] [Related]
9. Therapeutic hotline. Alefacept in the treatment of hyperkeratotic palmoplantar psoriasis.
Lior S; Grigory K; Pnina S; Joseph S; Felix P
Dermatol Ther; 2010; 23(5):556-60. PubMed ID: 20868412
[TBL] [Abstract][Full Text] [Related]
10. Biological therapy.
Roberts L
Nurs Stand; 2004 Nov 17-23; 19(10):21. PubMed ID: 15612428
[No Abstract] [Full Text] [Related]
11. Successful treatment of recalcitrant palmoplantar psoriasis with etanercept.
Weinberg JM
Cutis; 2003 Nov; 72(5):396-8. PubMed ID: 14655781
[TBL] [Abstract][Full Text] [Related]
12. Anti-TNF-alpha therapy in childhood pustular psoriasis.
Pereira TM; Vieira AP; Fernandes JC; Antunes H; Basto AS
Dermatology; 2006; 213(4):350-2. PubMed ID: 17135745
[No Abstract] [Full Text] [Related]
13. New treatments for psoriasis: which biologic is best?
Nelson AA; Pearce DJ; Fleischer AB; Balkrishnan R; Feldman SR
J Dermatolog Treat; 2006; 17(2):96-107. PubMed ID: 16766334
[TBL] [Abstract][Full Text] [Related]
14. How and when to use biologics in psoriasis.
Kircik LH; Gonzalez ME
J Drugs Dermatol; 2010 Aug; 9(8 Suppl ODAC Conf Pt 2):s106-17. PubMed ID: 20715393
[No Abstract] [Full Text] [Related]
15. The use of cyclosporine in dermatology: part I.
Amor KT; Ryan C; Menter A
J Am Acad Dermatol; 2010 Dec; 63(6):925-46; quiz 947-8. PubMed ID: 21093659
[TBL] [Abstract][Full Text] [Related]
16. Clinical effectiveness and safety experience with alefacept in the treatment of patients with moderate-to-severe chronic plaque psoriasis in Taiwan: results of an open-label, single-arm, multicentre pilot study.
Huang PH; Liao YH; Wei CC; Tseng YH; Ho JC; Tsai TF
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):923-30. PubMed ID: 18312328
[TBL] [Abstract][Full Text] [Related]
17. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial.
Krueger GG; Langley RG; Finlay AY; Griffiths CE; Woolley JM; Lalla D; Jahreis A
Br J Dermatol; 2005 Dec; 153(6):1192-9. PubMed ID: 16307657
[TBL] [Abstract][Full Text] [Related]
18. Treatment of moderate-to-severe psoriasis with alefacept for up to one year: a case series.
Shah A; O'Neill J; Feldman SR
J Drugs Dermatol; 2010 Dec; 9(12):1491-4. PubMed ID: 21120256
[TBL] [Abstract][Full Text] [Related]
19. Alefacept revisited: Our 3-year clinical experience in 200 patients with chronic plaque psoriasis.
Perlmutter A; Cather J; Franks B; Jaracz E; Menter A
J Am Acad Dermatol; 2008 Jan; 58(1):116-24. PubMed ID: 17997502
[TBL] [Abstract][Full Text] [Related]
20. Differing patterns of methotrexate use for psoriatic disease among dermatologists and rheumatologists.
Dupuis EC; Bhole VM; Dutz JP
Br J Dermatol; 2012 Aug; 167(2):448-50. PubMed ID: 22309601
[No Abstract] [Full Text] [Related]
[Next] [New Search]
